| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS4A6A | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-08 |
| mRNA | CA1 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-08 |
| mRNA | MS4A2 | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-09 |
| mRNA | SNX20 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | SAMSN1 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | C10orf128 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | OSM | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | EPB42 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-10 |
| mRNA | AHSP | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-10 |
| mRNA | HBM | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-10 |
